{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:34:53Z","timestamp":1793313293298,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijtb.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T12:13:00Z","timestamp":1556712780000},"page":"487-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The roles of latency-associated antigens in tuberculosis vaccines"],"prefix":"10.1016","volume":"66","author":[{"given":"Arshid","family":"Yousefi Avarvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Tafaghodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ahmadipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijtb.2019.04.012_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1473-3099(06)70602-8","article-title":"Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review","volume":"6","author":"Steingart","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijtb.2019.04.012_bib2","series-title":"Global Tuberculosis Report 2018","author":"Organization World Health (WHO)","year":"2018"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib3","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Lucia","year":"2013","journal-title":"Medicina"},{"key":"10.1016\/j.ijtb.2019.04.012_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.meegid.2016.01.027","article-title":"Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine","volume":"39","author":"Mosavat","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"7","key":"10.1016\/j.ijtb.2019.04.012_bib5","first-page":"2189","article-title":"Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6: CFP-10 complex","volume":"12","author":"Farsiani","year":"2016","journal-title":"Mol Bio Syst"},{"issue":"24","key":"10.1016\/j.ijtb.2019.04.012_bib6","doi-asserted-by":"crossref","first-page":"10467","DOI":"10.1007\/s00253-015-6952-z","article-title":"APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice","volume":"99","author":"Soleimanpour","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"10.1016\/j.ijtb.2019.04.012_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.job.2012.04.002","article-title":"Current status of tuberculosis and recombinant bacillus Calmette-Gu\u00e9rin vaccines","volume":"54","author":"Ohara","year":"2012","journal-title":"J Oral Biosci"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14760584.2018.1406309","article-title":"Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?","volume":"17","author":"Khademi","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.ijtb.2019.04.012_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072745","article-title":"Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice","volume":"8","author":"Xin","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijtb.2019.04.012_bib10","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.43950","article-title":"Designing a novel multi-epitope DNA-based vaccine against tuberculosis: in silico approach","volume":"10","author":"Moradi","year":"2017","journal-title":"Jundishapur J Microbiol"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib11","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1080\/21505594.2018.1514237","article-title":"Transcription factors Rv0081 and Rv3334 connect the early and the enduring hypoxic response of Mycobacterium tuberculosis","volume":"9","author":"Sun","year":"2018","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12864-018-4947-8","article-title":"Understanding the role of interactions between host and Mycobacterium tuberculosis under hypoxic condition: an in silico approach","volume":"19","author":"Bose","year":"2018","journal-title":"BMC Genomics"},{"issue":"4","key":"10.1016\/j.ijtb.2019.04.012_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1472-9792(03)00052-0","article-title":"Resuscitation factors from mycobacteria: homologs of Micrococcus luteus proteins","volume":"83","author":"Zhu","year":"2003","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.micinf.2011.08.011","article-title":"Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines","volume":"14","author":"Romano","year":"2012","journal-title":"Microb Infect"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/0074-02760140140","article-title":"The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients","volume":"109","author":"Silva","year":"2014","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz."},{"key":"10.1016\/j.ijtb.2019.04.012_bib16","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3389\/fimmu.2018.02476","article-title":"A systematic review on novel Mycobacterium tuberculosis antigens and their discriminatory potential for the diagnosis of latent and active tuberculosis","volume":"9","author":"Meier","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00140009","article-title":"Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection","volume":"36","author":"Goletti","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2019.04.012_bib18","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.3389\/fmicb.2017.02266","article-title":"Mycobacterium tuberculosis latent antigen Rv2029c from the multistage DNA vaccine A39 drives TH1 responses via TLR-mediated macrophage activation","volume":"8","author":"Su","year":"2017","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.ijtb.2019.04.012_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2958.2007.06078.x","article-title":"The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in\u00a0vitro","volume":"67","author":"Kana","year":"2008","journal-title":"Mol Microbiol"},{"issue":"7","key":"10.1016\/j.ijtb.2019.04.012_bib20","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/eji.201445329","article-title":"Mycobacterium tuberculosis RpfE promotes simultaneous Th1-and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells","volume":"45","author":"Choi","year":"2015","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.ijtb.2019.04.012_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7774\/cevr.2014.3.2.235","article-title":"DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8+ T cell responses","volume":"3","author":"Lee","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"issue":"5","key":"10.1016\/j.ijtb.2019.04.012_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/1040841X.2017.1283485","article-title":"Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection","volume":"43","author":"Rosser","year":"2017","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib23","first-page":"15","article-title":"Mycobacterium tuberculosis HspX\/EsxS fusion protein: gene cloning, protein expression, and purification in Escherichia coli","volume":"6","author":"Khademi","year":"2017","journal-title":"Rep Biochem Mol Biol"},{"key":"10.1016\/j.ijtb.2019.04.012_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/icb.2009.14","article-title":"TB vaccines: current status and future perspectives","volume":"87","author":"Aagaard","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.ijtb.2019.04.012_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075684","article-title":"ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation","volume":"8","author":"Marongiu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2019.04.012_bib26","article-title":"Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-\u03b3+ IL-2+ CD4+ and IFN-\u03b3+ CD8+ T cells","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2019.04.012_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-3083.2011.02531.x","article-title":"Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice","volume":"73","author":"Li","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.ijtb.2019.04.012_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047781","article-title":"Immunogenicity of a fusion protein containing immunodominant epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in mice and active TB infection","volume":"7","author":"de Sousa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2019.04.012_bib29","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.vaccine.2011.06.029","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice","volume":"30","author":"Yuan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ijtb.2019.04.012_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.micinf.2010.11.002","article-title":"The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis","volume":"13","author":"Jeon","year":"2011","journal-title":"Microb Infect"},{"key":"10.1016\/j.ijtb.2019.04.012_bib31","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1007\/s00253-015-6962-x","article-title":"A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection","volume":"99","author":"Yuan","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.ijtb.2019.04.012_bib32","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1128\/IAI.01990-06","article-title":"T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination","volume":"75","author":"Geluk","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijtb.2019.04.012_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112848","article-title":"A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis","volume":"9","author":"da Costa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2019.04.012_bib34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.micpath.2018.10.023","article-title":"A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity","volume":"125","author":"Khademi","year":"2018","journal-title":"Microb Pathog"},{"issue":"6","key":"10.1016\/j.ijtb.2019.04.012_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/apm.12851","article-title":"Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB\/c mice using PLGA and DOTAP adjuvant","volume":"126","author":"Khademi","year":"2018","journal-title":"Apmis"},{"issue":"2","key":"10.1016\/j.ijtb.2019.04.012_bib36","first-page":"156","article-title":"Increasing cellular immune response in liposomal formulations of DOTAP encapsulated by fusion protein Hspx, PPE44, and Esxv, as a potential tuberculosis vaccine candidate","volume":"7","author":"Mansury","year":"2019","journal-title":"Rep Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.ijtb.2019.04.012_bib37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s12257-016-0326-y","article-title":"TB trifusion antigen adsorbed on calcium phosphate nanoparticles stimulates strong cellular immunity in mice","volume":"21","author":"Amini","year":"2016","journal-title":"Biotechnol Bioprocess Eng"},{"key":"10.1016\/j.ijtb.2019.04.012_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130641","article-title":"Multi-stage tuberculosis subunit vaccine candidate LT69 provides high protection against Mycobacterium tuberculosis infection in mice","volume":"10","author":"Niu","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ijtb.2019.04.012_bib39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/CVI.00217-16","article-title":"Multifunctional T cell response to DosR and Rpf antigens is associated with protection in long-term Mycobacterium tuberculosis-infected individuals in Colombia","volume":"23","author":"Arroyo","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/1471-2334-14-495","article-title":"Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2 weeks of anti-TB therapy is characterized by high expression of IFN-\u03b3 and Granzyme B and inter-individual variation","volume":"14","author":"Mensah","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.ijtb.2019.04.012_bib41","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/CVI.00482-12","article-title":"Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis","volume":"19","author":"Kassa","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.ijtb.2019.04.012_bib42","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/eji.201141602","article-title":"Double-and monofunctional CD4+ and CD8+ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals","volume":"41","author":"Commandeur","year":"2011","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.ijtb.2019.04.012_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vaccine.2010.10.022","article-title":"Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease","volume":"29","author":"Govender","year":"2010","journal-title":"Vaccine"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001957071630381X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001957071630381X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:57:44Z","timestamp":1758081464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001957071630381X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S001957071630381X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2019.04.012","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The roles of latency-associated antigens in tuberculosis vaccines","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of Tuberculosis Association of India.","name":"copyright","label":"Copyright"}]}}